SFG CrossLab | Next-Generation Personalized Cancer Therapy: The “Whack-A-Mole” combination approach for precision oncology

Wednesday, February 28, 3:00pm - 4:00pm (EST)

Time shown in-05:00 America, New York

Dr. Daisuke Nishizaki is a gastrointestinal surgeon from Kyoto University with a background in clinical epidemiology. Currently engaged in the investigation of genomic and immune biomarker analyses to advance personalized cancer therapy approach with Dr. Shumei Kato in UC San Diego.

Click Here: Zoom Link

Please fill out the information below to register for the event.

Going
Interested
Can't go

Name

Attending

You're going to "SFG CrossLab | Next-Generation Personalized Cancer Therapy: The “Whack-A-Mole” combination approach for precision oncology".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Add to Calendar 2024/02/28 12:00:00 2024/02/28 13:00:00 America/Los_Angeles SFG CrossLab | Next-Generation Personalized Cancer Therapy: The “Whack-A-Mole” combination approach for precision oncology Dr. Daisuke Nishizaki is a gastrointestinal surgeon from Kyoto University with a background in clinical epidemiology. Currently engaged in the investigation of genomic and immune biomarker analyses to advance personalized cancer therapy approach with Dr. Shumei Kato in UC San Diego.

Click Here: Zoom Link Comer Commons false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689

You're interested in "SFG CrossLab | Next-Generation Personalized Cancer Therapy: The “Whack-A-Mole” combination approach for precision oncology".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Thank you!

Your changes have been saved. Thanks for keeping us updated.

Comer Commons

Daisuke Nishizaki, MD

Link: